Changes in transition metal contents in rat brain regions after in vivo quinolinate intrastriatal administration - PubMed (original) (raw)
. 1996 Winter;27(4):449-52.
Affiliations
- PMID: 8987176
Changes in transition metal contents in rat brain regions after in vivo quinolinate intrastriatal administration
P Pérez et al. Arch Med Res. 1996 Winter.
Abstract
Total copper and manganese contents were measured in five rat brain regions 7 days after a unilateral striatal injection of quinolinic acid (QUIN, 240 nmol/ 1 microliter), an endogenous N-methyl-D-aspartate (NMDA) receptor agonist. Concentrations of both transition metals were evaluated in tissue of brain cortex, hippocampus, corpus striatum, midbrain and cerebellum of saline- and QUIN-treated rats using graphite furnace atomic absorption spectrophotometry. Increases in copper content were observed after QUIN striatal injection in cerebellum, hippocampus, midbrain and corpus striatum (37, 55, 71 and 152% as compared against control values, respectively) but not in brain cortex. Manganese levels were found enhanced only in corpus striatum of QUIN-treated rats by 35% vs. control values, but not in all other brain regions analyzed. QUIN-induced increases in regional copper content were partially prevented in hippocampus, midbrain and striatum (17, 57, and 23% vs. control, respectively) by pretreatment of rats with an NMDA receptor antagonist, dizocilpine (MK-801, 10 mg/kg, i.p.), administered 60 min before QUIN microinjection. The same protective effect of dizocilpine was observed against QUIN-induced enhancement of striatal manganese content (-0.45% vs. control). These findings resemble those changes observed in postmortem Huntington's disease brains and suggest that alterations in regional content of copper, but not in manganese, may be a consequence of the spreading of QUIN-induced neurotoxic events into the striatal tissue to the neighboring regions of the brain, by action of QUIN on NMDA receptors.
Similar articles
- Quinolinic acid neurotoxicity: in vivo increased copper and manganese content in rat corpus striatum after quinolinate intrastriatal injection.
Santamaría A, Ríos C, Pérez P, Flores A, Galván-Arzate S, Osorio-Rico L, Solís F. Santamaría A, et al. Toxicol Lett. 1996 Oct;87(2-3):113-9. doi: 10.1016/0378-4274(96)03772-1. Toxicol Lett. 1996. PMID: 8914619 - Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K. Harris CA, et al. Br J Pharmacol. 1998 May;124(2):391-9. doi: 10.1038/sj.bjp.0701834. Br J Pharmacol. 1998. PMID: 9641558 Free PMC article. - Human FGF-1 gene delivery protects against quinolinate-induced striatal and hippocampal injury in neonatal rats.
Hossain MA, Fielding KE, Trescher WH, Ho T, Wilson MA, Laterra J. Hossain MA, et al. Eur J Neurosci. 1998 Aug;10(8):2490-9. Eur J Neurosci. 1998. PMID: 9767380 - The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists.
Jhamandas KH, Boegman RJ, Beninger RJ. Jhamandas KH, et al. Can J Physiol Pharmacol. 1994 Dec;72(12):1473-82. doi: 10.1139/y94-213. Can J Physiol Pharmacol. 1994. PMID: 7736338 Review. - Quinolinic acid, the inescapable neurotoxin.
Guillemin GJ. Guillemin GJ. FEBS J. 2012 Apr;279(8):1356-65. doi: 10.1111/j.1742-4658.2012.08485.x. Epub 2012 Mar 27. FEBS J. 2012. PMID: 22248144 Review.
Cited by
- Drosophila melanogaster Models of Metal-Related Human Diseases and Metal Toxicity.
Calap-Quintana P, González-Fernández J, Sebastiá-Ortega N, Llorens JV, Moltó MD. Calap-Quintana P, et al. Int J Mol Sci. 2017 Jul 6;18(7):1456. doi: 10.3390/ijms18071456. Int J Mol Sci. 2017. PMID: 28684721 Free PMC article. Review. - Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
Nguyen T, Hamby A, Massa SM. Nguyen T, et al. Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11840-5. doi: 10.1073/pnas.0502177102. Epub 2005 Aug 8. Proc Natl Acad Sci U S A. 2005. PMID: 16087879 Free PMC article. - Studies on Copper and Aβ1-16-Induced Conformational Changes in CAG/CTG Trinucleotide Repeats Sequence.
Govindaraju M, Rao Jayanth KS, Jagadeesh Kumar D, Prasada Rao UJS, Sambasiva Rao KRS, Rao KS. Govindaraju M, et al. J Alzheimers Dis Rep. 2017 Dec 29;1(1):277-286. doi: 10.3233/ADR-170027. J Alzheimers Dis Rep. 2017. PMID: 30480244 Free PMC article. - Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding.
Xiao G, Fan Q, Wang X, Zhou B. Xiao G, et al. Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14995-5000. doi: 10.1073/pnas.1308535110. Epub 2013 Aug 26. Proc Natl Acad Sci U S A. 2013. PMID: 23980182 Free PMC article.